Profile and quality of published reviews on COVID-19.
作者信息
Pericàs Juan M, Torrallardona-Murphy Orla, Arenas Andrea, Valero Helena, Nicolás David
机构信息
Infectious Diseases, Internal Medicine Service, and Hospital at Home Unit, Medical and Nurse Direction, Hospital Clinic Barcelona, Universitat de Barcelona, Barcelona, Spain.
出版信息
Eur J Clin Invest. 2020 May 30;50(8):e13293. doi: 10.1111/eci.13293.
Abstract
摘要
相似文献
1
Profile and quality of published reviews on COVID-19.关于新冠病毒病（COVID-19）已发表综述的概况与质量
Eur J Clin Invest. 2020 May 30;50(8):e13293. doi: 10.1111/eci.13293.
2
Clinical Manifestations of COVID-19 in the Feet: A Review of Reviews.新型冠状病毒肺炎足部临床表现：综述之综述
J Clin Med. 2021 May 19;10(10):2201. doi: 10.3390/jcm10102201.
3
Duplication and nonregistration of COVID-19 systematic reviews: Bibliometric review.COVID-19系统评价的重复与未注册情况：文献计量学综述
Health Sci Rep. 2022 Apr 21;5(3):e541. doi: 10.1002/hsr2.541. eCollection 2022 May.
4
[Quality of systematic reviews of COVID-19 in people with diabetes: A systematic review].[糖尿病患者中COVID-19系统评价的质量：一项系统评价]
Enferm Clin. 2022 Nov-Dec;32(6):367-375. doi: 10.1016/j.enfcli.2022.06.003. Epub 2022 Jun 23.
5
Quality of systematic reviews of COVID-19 in people with diabetes: A systematic review.新型冠状病毒肺炎合并糖尿病患者系统评价的质量：一项系统评价。
Enferm Clin (Engl Ed). 2022 Nov-Dec;32(6):367-375. doi: 10.1016/j.enfcle.2022.06.004. Epub 2022 Jun 30.
6
COVID-19 and chronic kidney disease: an updated overview of reviews.COVID-19 与慢性肾脏病：系统评价的更新概述。
J Nephrol. 2022 Jan;35(1):69-85. doi: 10.1007/s40620-021-01206-8. Epub 2022 Jan 11.
7
Characteristics of registered and published systematic reviews focusing on the prevention of COVID-19: a meta-research study.关注 COVID-19 预防的注册和已发表系统评价的特征：一项元研究。
BMJ Open. 2022 May 9;12(5):e060255. doi: 10.1136/bmjopen-2021-060255.
8
Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses.秋水仙碱能否降低COVID-19临床综合征患者的死亡率？已发表的荟萃分析的综合评价。
Heliyon. 2023 Sep 16;9(10):e20155. doi: 10.1016/j.heliyon.2023.e20155. eCollection 2023 Oct.
9
Epidemiological, clinical and biomarker profile of pediatric patients infected with COVID-19.儿童 COVID-19 感染者的流行病学、临床和生物标志物特征。
QJM. 2021 Nov 5;114(7):476-495. doi: 10.1093/qjmed/hcab206.
10
Assessment of COVID-19-related meta-analysis reporting quality.COVID-19 相关荟萃分析报告质量评估。
Ir J Med Sci. 2022 Jun;191(3):1047-1051. doi: 10.1007/s11845-021-02710-3. Epub 2021 Jul 6.
引用本文的文献
1
COVID-19 meta-analyses: a scoping review and quality assessment.COVID-19 荟萃分析：范围综述和质量评估。
Einstein (Sao Paulo). 2021 Mar 15;19:eAO6002. doi: 10.31744/einstein_journal/2021AO6002. eCollection 2021.
本文引用的文献
1
Redundancy in reporting on COVID-19.关于新冠疫情报道中的冗余问题。
Eur J Clin Invest. 2020 Jun;50(6):e13257. doi: 10.1111/eci.13257. Epub 2020 May 18.
2
Exaggerated information and COVID-19 outbreak.夸大信息与新冠疫情爆发
Eur J Clin Invest. 2020 May;50(5):e13226. doi: 10.1111/eci.13226. Epub 2020 May 2.
3
Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures.2019冠状病毒病：夸大信息和非循证措施的危害。
Eur J Clin Invest. 2020 Apr;50(4):e13222. doi: 10.1111/eci.13222.
4
A catalogue of reporting guidelines for health research.健康研究报告规范目录。
Eur J Clin Invest. 2010 Jan;40(1):35-53. doi: 10.1111/j.1365-2362.2009.02234.x.
5
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.系统评价与Meta分析优先报告条目：PRISMA声明
PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.
6
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件